A Retrospective Real-World Comparison of Topical Delgocitinib and Localized Cream Psoralen–Ultraviolet A in Chronic Hand Eczema
Delgocitinib and PUVA provided comparable short-term clinical efficacy in CHE, with a numerically greater DLQI reduction for delgocitinib. Proactive delgocitinib maintenance may help sustain disease control. Subtype-adapted treatment strategies could further optimize outcomes.
Institutions
- LMU Klinikum (DE)
- München Klinik (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2026-03-24
- DOI
- https://doi.org/10.1007/s13555-026-01705-1
- Primary Topic
- Contact Dermatitis and Allergies
- Type
- article
- Field-Weighted Citation Impact
- 0.00